REGN Regeneron Pharmaceuticals, Inc.

NASDAQ
$945.53

Regeneron Pharmaceuticals, Inc. (REGN) Earnings News

Earnings press releases, previews and reviews for Regeneron Pharmaceuticals, Inc. (REGN), newest first. Our most recent is review: Regeneron's Sanofi Windfall Drives a 19.5% Beat, but the Retinal Franchise Is Still Treading Water.